ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 673421 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 673421; 2) Community: the network communities that were significantly associated with the response to NSC 673421; 3) Molecule: the relationships between components within communities and NSC 673421; 4) MDR: the compounds that were significantly associated with the NSC 673421.

NSC Compound Enrichment Correlation
NSC 630606 1-Piperidinecarboxylic acid, 3,5-bis(phenylmethylene)- 4-oxo-, 4-methylphenyl ester 0.00216534295403404 0.41480515
NSC 664271 Null 0.00216534295403404 0.55669838
NSC 72942 DL-Noformicin 0.00228818143845077 -0.32104501
NSC 736099 Null 0.00228818143845077 0.15732993
NSC 742295 (11aS)-8-(5-[4-(1,3-benzothiazol-2-yl)phenoxy]pentyloxy)-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one 0.00228818143845077 0.27996556
NSC 135168 Null 0.00270237426478987 0.062536462
NSC 682561 Cardenolide 2 0.00270237426478987 0.32277548
NSC 695930 Null 0.00270237426478987 0.19829404
NSC 760183 tert-butyl 2-((6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate 0.00270237426478987 0.064730354
NSC 357288 LIATRIS LAEVIGATA LACTONE #2 0.00313644776247642 0.44608648
Total:103  Current:12    [First] [Prev] [Next] [Last]